Bildkälla: Stockfoto

Saniona: Initiates Phase IIb Tesomet Trial in Hypothalamic Obesity - Redeye

Saniona announced today that it has initiated its phase IIb trial in HO, one of two phase IIb studies expected to start in 2021. We give a shorter comment on the positive news.

Saniona announced today that it has initiated its phase IIb trial in HO, one of two phase IIb studies expected to start in 2021. We give a shorter comment on the positive news.
Börsvärldens nyhetsbrev
ANNONSER